GlassScriptPhysician profile
Ronald Buckley
NPI 1871559567
$6,483.08
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $335 · 2020: $276 · 2021: $644 · 2022: $1,202 · 2023: $1,592 · 2024: $2,434.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,822 · Education: $204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,821.69 |
| Education | $204.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,732.86 | 2019-2024 | Rinvoq, Skyrizi |
| Janssen Biotech, INC. | $1,000.91 | 2020-2024 | Tremfya, Simponi Aria, Simponi |
| E.R. Squibb & Sons, L.L.C. | $499.22 | 2022-2024 | Sotyktu |
| Amgen INC. | $458.11 | 2020-2024 | Otezla, Enbrel |
| Leo Pharma INC. | $341.88 | 2021-2023 | Adbry |
| Pfizer INC. | $332.15 | 2019-2023 | |
| Lilly USA, LLC | $330.09 | 2021-2024 | Taltz |
| Genzyme Corporation | $318.12 | 2021-2024 | |
| Regeneron Healthcare Solutions, INC. | $252.40 | 2019-2024 | Dupixent |
| Novartis Pharmaceuticals Corporation | $237.39 | 2021-2024 | |
| Sun Pharmaceutical Industries INC. | $212.78 | 2019-2024 | |
| Galderma Laboratories, L.P. | $203.74 | 2024 | Aklief |
| Arcutis Biotherapeutics, INC. | $182.90 | 2023-2024 | Zoryve |
| Dermavant Sciences, INC. | $87.78 | 2023-2024 | Vtama |
| Ucb, INC. | $86.70 | 2021-2024 | Bimzelx |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $43.73 | 2020-2021 | |
| Incyte Corporation | $42.34 | 2021-2022 | |
| Vyne Pharmaceuticals INC. | $32.79 | 2020 | |
| Paratek Pharmaceuticals, INC. | $31.19 | 2023 | Nuzyra |
| Bausch Health US, LLC | $29.61 | 2024 | Siliq, Targretin |
| Sandoz INC. | $26.39 | 2023 | Hyrimoz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Buckley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.